CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- S-3/A Offering Registration Statement
- DEF 14A Proxy Proxy Statement
- UPLOAD Other SEC-generated Letter
- PRE 14A Proxy Proxy Statement (Preliminary)
- S-3 Offering Registration Statement
- 8-K Event Results of operations
- 10-K Report Annual Report
- NT 10-K Other NT 10-K
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market sale Chief Operating Officer sold 4,368 shares at $3.19 ($13,942)
- 4 Open-market sale Chief Patient Supply Officer sold 4,368 shares at $3.19 ($13,942)
- 4 Open-market sale Chief Medical Officer sold 2,121 shares at $3.19 ($6,770)
- 4 Open-market sale Chief Executive Officer sold 11,096 shares at $3.19 ($35,416)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Operating Officer sold 6,018 shares at an average $3.55 ($21,376)
Page 14 of 41 · 808 filings